Follow
'Tinto ran an influential early study of the vaccine, starting in 2019 (M. S. Datoo et al. Lancet397, 1809–1818; 2021). “He led the trial that really, to people in the field, showed that this vaccine was going to be different,” says Adrian Hill, a vaccinologist at the University of Oxford, UK, who oversaw the development of R21.'
#Malaria
